Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis. / Recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología sobre el manejo de la psoriasis en pacientes oncológicos.

Puig, L; Notario, J; López-Ferrer, A; Scheneller-Pavelescu, L; Pérez, B; Galache, C; de la Cueva, P; Carrascosa, J M.

Actas Dermosifiliogr ; 2024 Feb 19.

Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-38382743

2.

Validation of the Spanish Version of the PURE-4 Questionnaire for the Early Detection of Psoriatic Arthritis in Psoriatic Patients. / Validación de la versión española del cuestionario PURE-4 para la detección precoz de la artritis psoriásica en pacientes con psoriasis.

Belinchón-Romero, I; López-Ferrer, A; Ferrán I Farrés, M; Rivera-Díaz, R; Vidal-Sarro, D; Rodríguez Fernández-Freire, L; de la Cueva-Dobao, P; Santos-Juanes, J; Rocamora-Durán, V; Martín-Vázquez, V; Gómez-Labradror, L; Queiro-Silva, R.

Actas Dermosifiliogr ; 2024 Feb 19.

Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-38382746

3.

Definition of minimal disease activity in psoriasis.

Carretero, G; Carrascosa, J M; Puig, L; Sánchez-Carazo, J L; López-Ferrer, A; Cueva, P; Soria, C; Rivera, R; Belinchón, I.

J Eur Acad Dermatol Venereol ; 35(2): 422-430, 2021 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-32367536

4.

Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group.

Del Alcázar, E; Suárez-Pérez, J A; Armesto, S; Rivera, R; Herrera-Acosta, E; Herranz, P; Martín, I; Montesinos, E; Hospital, M; Vilarrasa, E; Ferran, M; Ruiz-Villaverde, R; Sahuquillo-Torralba, A; Ruiz-Genao, D P; Pérez-Barrio, S; Muñoz, C; Llamas, M; Valentí, F; Mitxelena, M J; López-Ferrer, A; Carretero, G; Vidal, D; Mollet, J; Belinchón, I; Carrascosa, J M.

J Eur Acad Dermatol Venereol ; 34(12): 2821-2829, 2020 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-32271966

5.

Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study.

Deza, G; Notario, J; Lopez-Ferrer, A; Vilarrasa, E; Ferran, M; Del Alcazar, E; Carrascosa, J M; Corral, M; Salleras, M; Ribera, M; Puig, L; Pujol, R M; Vidal, D; Gallardo, F.

J Eur Acad Dermatol Venereol ; 33(3): 553-559, 2019 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-30317679

6.

Subclinical enthesopathy of extensor digitorum tendon is highly prevalent and associated with clinical and ultrasound alterations of the adjacent fingernails in patients with psoriatic disease.

Moya Alvarado, P; Roé Crespo, E; Muñoz-Garza, F Z; López-Ferrer, A; Laiz Alonso, A; Vilarrassa Rull, E; Casademont I Pou, J; Puig Sanz, L.

J Eur Acad Dermatol Venereol ; 32(10): 1728-1736, 2018 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-29706002

7.

Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis.

Iznardo, H; Vilarrasa, E; López-Ferrer, A; Puig, L.

Br J Dermatol ; 185(3): 660-662, 2021 09.

Artigo em Inglês | MEDLINE | ID: mdl-33913516

8.

Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain.

Puig, L; López-Ferrer, A; Vilarrasa, E; García, I; Fernández-del Olmo, R.

Actas Dermosifiliogr ; 107(1): 34-43, 2016.

Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-26365029

9.

Etanercept in the treatment of psoriatic arthritis.

Puig, L; López-Ferrer, A; Laiz, A.

Actas Dermosifiliogr ; 106(4): 252-9, 2015 May.

Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-25455504

10.

Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions.

Spertino, J; Lopez-Ferrer, A; Vilarrasa, E; Puig, L.

J Eur Acad Dermatol Venereol ; 28(11): 1514-21, 2014 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-25493314

11.

Psoriatic arthritis: an update.

López-Ferrer, A; Laiz-Alonso, A.

Actas Dermosifiliogr ; 105(10): 913-22, 2014 Dec.

Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-24674606

12.

Vismodegib: a review.

Ruiz-Salas, V; Alegre, M; López-Ferrer, A; Garcés, J R.

Actas Dermosifiliogr ; 105(8): 744-51, 2014 Oct.

Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-24359667

13.

Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre.

López-Ferrer, A; Vilarrasa, E; Gich, I J; Puig, L.

Br J Dermatol ; 169(5): 1141-7, 2013 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-23909993

14.

Triple paradoxical reaction due to adalimumab.

Mir-Bonafe, J F; Lopez-Ferrer, A; Laiz, A; Puig, L.

J Eur Acad Dermatol Venereol ; 31(2): e71-e73, 2017 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-27291419

15.

[Botulinum toxin A for the treatment of familial benign pemphigus]. / Toxina botulínica A en el tratamiento del pénfigo benigno familiar.

López-Ferrer, A; Alomar, A.

Actas Dermosifiliogr ; 103(6): 532-5, 2012.

Artigo em Espanhol | MEDLINE | ID: mdl-21872830

16.

Crusted (Norwegian) scabies: an under-recognized infestation characterized by an atypical presentation and delayed diagnosis.

Yélamos, O; Mir-Bonafé, J F; López-Ferrer, A; Garcia-Muret, M P; Alegre, M; Puig, L.

J Eur Acad Dermatol Venereol ; 30(3): 483-5, 2016 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-25428862

17.

Psoriatic Arthritis: What the Dermatologist needs to Know, Part 1. / Artritis psoriásica: lo que el dermatólogo debe saber (Parte 1).

López-Ferrer, A; Torrente-Segarra, V; Puig, L.

Actas Dermosifiliogr ; 101(7): 578-584, 2010 Sep.

Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28709540

18.

[Psoriatic arthritis: what the dermatologist needs to know, Part 2]. / Artritis psoriásica. Lo que el dermatólogo debe saber (Parte 2).

López-Ferrer, A; Torrente-Segarra, V; Puig, L.

Actas Dermosifiliogr ; 101(9): 742-8, 2010 Nov.

Artigo em Espanhol | MEDLINE | ID: mdl-21034704

19.

[Psoriatic arthritis: what the dermatologist needs to know, part 1]. / Artritis psoriásica: lo que el dermatólogo debe saber (Parte 1).

López-Ferrer, A; Torrente-Segarra, V; Puig, L.

Actas Dermosifiliogr ; 101(7): 578-84, 2010 Sep.

Artigo em Espanhol | MEDLINE | ID: mdl-20858384

20.

Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic Arthritis UnclutteRed Screening Evaluation (PURE4). / Adaptación lingüística y cultural al español del cuestionario Psoriatic arthritis UnclutteRed screening Evaluation (PURE-4).

Belinchón, I; Queiro, R; Salgado-Boquete, L; López-Ferrer, A; Ferran, M; Coto-Segura, P; Rivera, R; Vidal, D; Rodríguez, L; de la Cueva, P; Guinea, G; Martin Vazquez, V.

Actas Dermosifiliogr (Engl Ed) ; 111(8): 655-664, 2020 Oct.

Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32401721

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Validation of the Spanish Version of the PURE-4 Questionnaire for the Early Detection of Psoriatic Arthritis in Psoriatic Patients. / Validación de la versión española del cuestionario PURE-4 para la detección precoz de la artritis psoriásica en pacientes con psoriasis.

Definition of minimal disease activity in psoriasis.

Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group.

Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study.

Subclinical enthesopathy of extensor digitorum tendon is highly prevalent and associated with clinical and ultrasound alterations of the adjacent fingernails in patients with psoriatic disease.

Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis.

Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain.

Etanercept in the treatment of psoriatic arthritis.

Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions.

Psoriatic arthritis: an update.

Vismodegib: a review.

Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre.

Triple paradoxical reaction due to adalimumab.

[Botulinum toxin A for the treatment of familial benign pemphigus]. / Toxina botulínica A en el tratamiento del pénfigo benigno familiar.

Crusted (Norwegian) scabies: an under-recognized infestation characterized by an atypical presentation and delayed diagnosis.

Psoriatic Arthritis: What the Dermatologist needs to Know, Part 1. / Artritis psoriásica: lo que el dermatólogo debe saber (Parte 1).

[Psoriatic arthritis: what the dermatologist needs to know, Part 2]. / Artritis psoriásica. Lo que el dermatólogo debe saber (Parte 2).

[Psoriatic arthritis: what the dermatologist needs to know, part 1]. / Artritis psoriásica: lo que el dermatólogo debe saber (Parte 1).

Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic Arthritis UnclutteRed Screening Evaluation (PURE4). / Adaptación lingüística y cultural al español del cuestionario Psoriatic arthritis UnclutteRed screening Evaluation (PURE-4).